R&D Award to Abdi İbrahim in 5 Categories

Abdi İbrahim, the uninterrupted leader of the Turkish pharmaceutical industry for 21 years, received awards in 5 categories at the Crystal Mortar Awards organized by the Chemists' Association.

 Acting for 111 years with the mission of improving life, Abdi İbrahim received awards in 5 categories at the Crystal Mortar Awards, given within the scope of the 11th International Pharmaceutical Chemistry Congress for its R&D studies and investments. On the opening day of the 11th International Pharmaceutical Chemistry Congress organized by the Chemists' Association in Antalya this year, the R&D activities of pharmaceutical companies were awarded in 7 categories. Abdi İbrahim won awards in 5 categories, including the “Pharmaceutical Company with the Most R&D Investments” category.

“We continue our R&D investments without slowing down”

Pointing out that Abdi İbrahim is one of the companies making the highest R&D investments in Türkiye, Abdi İbrahim R&D Director Udaya Dude said: “Our R&D and innovation efforts focus on high-tech, high value-added products that we believe will give our company a competitive edge in national and international markets. Our efforts to develop products and business models that differentiate us from competitors in the field of consumer health and to produce our own biotechnological drugs in the field of biotechnology continue uninterruptedly. Our R&D vision plays a major role and contributes to these efforts. Our R&D center has the capability and infrastructure to develop drugs using inhalation technology and nanotechnological methods in order to respond to the changing and evolving needs of the national and international pharmaceutical industry. In addition to the projects carried out within the company, we transfer know-how through joint projects with scientific institutions in Türkiye and abroad. Within the framework of our vision to take new steps towards the future of our country and the pharmaceutical industry, we will continue our R&D activities without slowing down. The fact that our investments in this field are crowned with awards in such prestigious organizations both delights us and motivates us to do better.”

 

The categories in which Abdi İbrahim won awards are as follows:

 

2021 Pharmaceutical companies with the highest R&D expenditures 2021 Pharmaceutical companies with the highest number of projects in their R&D centers 2021 Pharmaceutical companies employing the most personnel in R&D centers 2021 Number of female personnel working in R&D centers 2021 Number of personnel with master's and doctorate degrees working in R&D centers